Fusidic Acid Cream Suppliers & Bulk Manufacturers
Available Forms: Cream
Available Strengths: 2%,
Reference Brands: Fucidin(EU)
Category:
Derma Drugs
Fusidic acid cream inhibits bacterial protein synthesis by blocking isoleucyl-tRNA synthetase, effectively treating skin infections like impetigo and infected dermatitis. It provides rapid infection control, reduces bacteria spread, and lowers resistance risk, supporting targeted, effective topical antibacterial therapy for bacterial skin infections.
Fusidic Acid Cream is available in Cream
and strengths such as 2%,.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fusidic Acid Cream is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fusidic Acid Cream can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fusidic acid cream is approved in the EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP and IVDR standards. In the US, fusidic acid is not widely available or approved, limiting regulatory approval options, but compounded formulations may be used. In the EU, CE marking certifies conformity with in vitro diagnostic regulations and regional requirements. These products undergo validation, stability testing, and quality audits, with thorough documentation including safety profiles, clinical data, and manufacturing details. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective fusidic acid formulations for bacterial skin infections worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing